The One Health concept requesst to consider also environmental consequences of, amongst others, a drug used to combat parasitic vector born disease. This workshop will bring together experts in the field of ecotoxicology and environmental risk assessment of chemicals in a wider sense to share their knowledge on the environmental risk assessment, procedure of pharmaceuticals, and ways to predict and text potential environmental risks of chemicals also early in the drug product development process. As this seems a field of high interest for members in this Cost Action and beyond, we hope the workshop will shed some light.

Final program and registration

In silico tools for screening of environmental hazard early in the drug development process by João Barbosa

COST
What is COST?

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. The COST ACTIONS help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.

OneHealthdrugs CA21111
Title:

One Health drugs against parasitic vector borne diseases in Europe and beyond

Acronym:

OneHealthdrugs

Start date of the Action:

24/10/2022

End date of the Action:

23/10/2026

CSO approval date:

27/05/2022

Memorandum of Understanding (MoU)

Download file

Contact Points
Chair:

Maria Paola Costi

Vice-Chair:

Anabela Cordeiro da Silva

COST staff

Scientific Officer:
Lucia Forzi
Administrative Officer:
Nathalie Warenghien

Administrative Team

Maria Cristina Notarsanto
Maria Esposito and Laura Leonardi